Shopping? Check out our latest product comparisons

Nanosponges used to soak up toxins in the bloodstream

By

April 15, 2013

A rendering of the nanosponges attracting bloodstream-borne toxins

A rendering of the nanosponges attracting bloodstream-borne toxins

Image Gallery (3 images)

If you’ve seen many old westerns, then you’ll likely have watched a few scenes where one cowboy has to suck rattlesnake venom out of another one’s leg. Things would have been much easier for those cowboys if nanosponges had been around at the time. Developed by scientists at the University of California, San Diego, the tiny sponges mimic red blood cells, and are able to soak up lethal toxins – including snake venom and bacteria – from the bloodstream.

The nanosponges are made up of a biocompatible polymer core, which is coated with segments of the host’s red blood cell membranes. That coating fools the immune system into identifying the sponges as the body’s own blood cells, so it doesn’t attack them. Because each nanosponge is 3,000 times smaller than a red blood cell, the harvested membrane of one cell provides enough material to coat thousands of sponges.

The polymer core (white) is coated with segments of red blood cell membranes (orange)

The polymer core (white) is coated with segments of red blood cell membranes (orange)

When injected into the bloodstream, the nanosponges attract “pore-forming toxins,” just like real red blood cells. These toxins are produced not only by snake and insect venom, but also by bacteria such as MRSA (methicillin-resistant Staphylococcus aureus) and E. coli. They kill cells by perforating their outer membranes.

So many of the nanosponges are injected that they end up actually outnumbering the real red blood cells in the bloodstream. This results in the majority of the toxins attaching themselves to the sponges, leaving most of the blood cells alone. Those toxin-laden sponges are then carried to the liver, where both the polymer and the toxins are safely metabolized with no harmful effects to the body.

In lab trials, 89 percent of mice survived lethal doses of alpha-haemolysin toxin from MRSA, if first inoculated with the nanosponges. That figure decreased to 44 percent when the sponges were injected after exposure to the toxin.

One of the other good features of the nanosponges is the fact that in their stock form, they can neutralize a variety of toxins – other anti-toxins must be custom-synthesized in order to absorb specific toxins, with no one substance being effective against such a broad range.

Clinical trials of the nanosponges are now being planned. The project was led by Prof. Liangfang Zhang, and described in a paper recently published in the journal Nature Nanotechnology.

More information is available in the video below.

Source: University of California, San Diego

About the Author
Ben Coxworth An experienced freelance writer, videographer and television producer, Ben's interest in all forms of innovation is particularly fanatical when it comes to human-powered transportation, film-making gear, environmentally-friendly technologies and anything that's designed to go underwater. He lives in Edmonton, Alberta, where he spends a lot of time going over the handlebars of his mountain bike, hanging out in off-leash parks, and wishing the Pacific Ocean wasn't so far away.   All articles by Ben Coxworth
Tags
2 Comments

I love it when Sci-fi becomes Sci-fact :)

Cannon fodder nano-particles.

Impressive results from the LD mouse trial

Craig Jennings
15th April, 2013 @ 03:21 pm PDT

Sounds great but get the facts regarding your example with snake venom. Snake venom is not dispersed via the veins but through the lymphatic system. Cutting and "sucking out the venom" simply hastened the victims death.

greytoma
16th April, 2013 @ 04:15 pm PDT
Post a Comment

Login with your gizmag account:

Or Login with Facebook:


Related Articles
Looking for something? Search our 28,280 articles